Centessa Pharmaceuticals presented preclinical data for its investigational orexin receptor 2 agonist, ORX750, for the treatment of narcolepsy and other sleep-wake disorders.
AI Assistant
CENTESSA PHARMACEUTICALS PLC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.